Spineway confirmed acquisition of an equity stake in Integral Medical Solutions (IMS), a holding company that manages private hospitals in Latin America.
The stake, as well as a pending partnership and distribution agreement with IMS and its affiliates, supports Spineway’s position in the region which represented 50% of its 2018 sales and opens the door to expansion in the African continent, as well. IMS owns three hospitals in Columbia, and manages a network of hospitals in Africa.
Within four years, Spineway will have the option to increase its stake to 52% of IMS’ capital, and holds a promise of sale allowing for acquisition of all of IMS’ capital in five years. Spineway expects that these first steps toward large-scale vertical integration could create a new group worth over €80MM in revenue, based on 2018 figures.
In conjunction with this project, Spineway is pursuing a strategy to redeploy its activities in the U.S.
Source: Spineway
Spineway confirmed acquisition of an equity stake in Integral Medical Solutions (IMS), a holding company that manages private hospitals in Latin America.
The stake, as well as a pending partnership and distribution agreement with IMS and its affiliates, supports Spineway's position in the region which represented 50% of its 2018 sales and opens...
Spineway confirmed acquisition of an equity stake in Integral Medical Solutions (IMS), a holding company that manages private hospitals in Latin America.
The stake, as well as a pending partnership and distribution agreement with IMS and its affiliates, supports Spineway’s position in the region which represented 50% of its 2018 sales and opens the door to expansion in the African continent, as well. IMS owns three hospitals in Columbia, and manages a network of hospitals in Africa.
Within four years, Spineway will have the option to increase its stake to 52% of IMS’ capital, and holds a promise of sale allowing for acquisition of all of IMS’ capital in five years. Spineway expects that these first steps toward large-scale vertical integration could create a new group worth over €80MM in revenue, based on 2018 figures.
In conjunction with this project, Spineway is pursuing a strategy to redeploy its activities in the U.S.
Source: Spineway
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.